Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

INTRODUCTION: Targeting HER2 has improved outcomes in metastatic GE (mGE) cancer. In this study, we aim to explore the feasibility of molecular profiling in patients with refractory mGE cancer in routine clinical practice. METHODS: Archival formalin-fixed, paraffin-embedded (FFPE) samples for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhail, Sameh, Ciombor, Kristen, Noonan, Anne, Wu, Christina, Goldberg, Richard, Zhao, Weiqiang, Wei, Lai, Mathey, Kristina, Yereb, Melissa, Timmers, Cynthia, Bekaii-Saab, Tanios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673157/
https://www.ncbi.nlm.nih.gov/pubmed/26082439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673157/
https://www.ncbi.nlm.nih.gov/pubmed/26082439

Ejemplares similares